China’s Drug Control Agency Denies Trump’s Allegations of Supplying Fentanyl to US
On August 20, President Trump blamed China for supplying the synthetic opioid fentanyl that’s devastating U.S. communities. In a strongly-worded tweet, Trump accused China of moving the drug through the U.S. Postal System. The tweet marks the second time Trump has accused China of playing a role in the U.S.’s ongoing opioid crisis, and China’s Drug Control Agency’s rejection of those claims marks the second time they’ve disputed them. Evidence to support Trump’s claims has not been provided, Beijing officials say. This back-and-forth is once again heightening the already-tense relations between the two nations.
China Again Denies “Flooding” the U.S. with Fentanyl
Prior to his November 2017 visit to China, President Trump claimed that China was the producer of most of the synthetic opioid fentanyl coming into the United States. He also stated that he would discuss the issue with President Xi Jinping at their Beijing meeting. And just days ahead of the visit, Chinese officials rejected Trump’s claim.
Wei Xiaojun, deputy director general of the Narcotics Control Bureau of the Ministry of Public Security, acknowledged that in some individual cases, fentanyl manufactured illicitly in China had ended up in the United States. But Wei expressly denied the claim that